TELA Bio (NASDAQ:TELA – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, March 21st. Analysts expect the company to announce earnings of ($0.58) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link. TELA Bio Stock […]
TELA Bio (NASDAQ:TELA – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, March 21st. Analysts expect TELA Bio to post earnings of ($0.58) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link. TELA […]
Company grows product portfolio, expanding product offerings to optimize soft tissue preservation and restorationMALVERN, Pa., Jan. 09, 2023 TELA Bio, Inc. , a commercial-stage medical. | January 9, 2023
Study results show a low 2.6% recurrence rate and clinically meaningful improvement in patient quality of lifeMALVERN, Pa., Oct. 26, 2022 TELA Bio, Inc. , a commercial-stage medical technology. | October 26, 2022
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, purchased 5,000 shares of the firm’s stock in a transaction that occurred on Friday, June 10th. The stock was purchased at an average price of $5.80 per share, for a total transaction of $29,000.00. Following the acquisition, the insider now owns 3,500,709 […]